Logotype for Avecho Biotechnology Limited

Avecho Biotechnology (AVE) investor relations material

Avecho Biotechnology Q2 2025 TU earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Avecho Biotechnology Limited
Q2 2025 TU earnings summary29 Jul, 2025

Executive summary

  • Phase III insomnia trial expanded with three new clinical sites in Sydney and the Gold Coast, accelerating recruitment to 131 participants, with interim results expected in early 2026.

  • Strategic planning for TGA registration and commercialisation underway following Avecho-Sandoz meetings.

  • TPM®-enhanced CBD capsule positioned to be the first registered OTC cannabidiol product for insomnia in Australia.

  • Licensing agreement with Sandoz AG for exclusive Australian rights; business development efforts expanded to international markets.

Financial highlights

  • Cash balance of A$5.9 million as at 30 June 2025.

  • Received A$1.66 million under the Australian Government's R&D Tax Incentive Scheme, used to repay A$1.04 million in R&D tax advances and support operations.

  • Net cash used in operating activities for the quarter was A$680,000.

  • Payments to related parties and associates during the quarter totaled approximately A$67,000.

Outlook and guidance

  • Interim analysis cohort enrolment expected to complete in H2 2025, with interim results anticipated in early 2026.

  • Continued focus on regulatory readiness and commercialisation, with active licensing discussions in multiple jurisdictions.

  • Positioned to capitalize on Australia's OTC CBD market, projected to exceed US$125 million annually.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Avecho Biotechnology earnings date

Logotype for Avecho Biotechnology Limited
Q3 202527 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Avecho Biotechnology earnings date

Logotype for Avecho Biotechnology Limited
Q3 202527 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Avecho Biotechnology Limited is an Australian pharmaceutical company focused on drug delivery systems. The company develops proprietary formulations that enhance the solubility and absorption of active pharmaceutical ingredients using lipid-based delivery platforms. Its technologies are applied in human health, animal health, and topical therapeutics. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage